cyclopentenyl cytosine has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, M; Lewicki, P; Mitchell, BS; Whang, P | 1 |
| Jordan, VC; Murphy, CS; Pink, JJ | 1 |
2 other study(ies) available for cyclopentenyl cytosine and Breast Neoplasms
| Article | Year |
|---|---|
Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Nucleolus; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cytidine; Cytidine Triphosphate; Female; Gene Silencing; Genes, p53; Histones; Humans; Immunohistochemistry; RNA, Small Interfering | 2011 |
Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
Topics: Blotting, Northern; Breast Neoplasms; Cell Division; Clone Cells; Cytidine; DNA Fingerprinting; DNA, Neoplasm; ErbB Receptors; Estradiol; Gene Expression; Humans; In Vitro Techniques; Polyunsaturated Alkamides; Receptors, Estrogen; Receptors, Progesterone; RNA, Messenger; Tamoxifen; Transforming Growth Factor alpha; Transforming Growth Factor beta; Tumor Cells, Cultured | 1990 |